209 related articles for article (PubMed ID: 16357142)
41. Altered G1 phase regulation in osteosarcoma.
Benassi MS; Molendini L; Gamberi G; Sollazzo MR; Ragazzini P; Merli M; Magagnoli G; Sangiorgi L; Bacchini P; Bertoni F; Picci P
Int J Cancer; 1997 Oct; 74(5):518-22. PubMed ID: 9355974
[TBL] [Abstract][Full Text] [Related]
42. Cyclin D1 and CDK4 activity contribute to the undifferentiated phenotype in neuroblastoma.
Molenaar JJ; Ebus ME; Koster J; van Sluis P; van Noesel CJ; Versteeg R; Caron HN
Cancer Res; 2008 Apr; 68(8):2599-609. PubMed ID: 18413728
[TBL] [Abstract][Full Text] [Related]
43. S-phase lengthening induced by p16(INK4a) overexpression in malignant cells with wild-type pRb and p53.
Chien WW; Domenech C; Catallo R; Salles G; Ffrench M
Cell Cycle; 2010 Aug; 9(16):3286-96. PubMed ID: 20703084
[TBL] [Abstract][Full Text] [Related]
44. Expression of G1 cell cycle regulators in rat liver upon repeated exposure to thioacetamide.
Kim KT; Han SY; Jeong JS
Korean J Hepatol; 2007 Mar; 13(1):81-90. PubMed ID: 17380078
[TBL] [Abstract][Full Text] [Related]
45. Cyclin D1 suppresses retinoblastoma protein-mediated inhibition of TAFII250 kinase activity.
Siegert JL; Rushton JJ; Sellers WR; Kaelin WG; Robbins PD
Oncogene; 2000 Nov; 19(50):5703-11. PubMed ID: 11126356
[TBL] [Abstract][Full Text] [Related]
46. [Decrease of cyclin D1 and CDK4 protein and their related factors induced by quartz in human embryonic lung fibroblasts].
Shen FH; Fan XY; Liu BC
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2008 Jul; 26(7):391-4. PubMed ID: 19080374
[TBL] [Abstract][Full Text] [Related]
47. Location, location, location: the role of cyclin D1 nuclear localization in cancer.
Gladden AB; Diehl JA
J Cell Biochem; 2005 Dec; 96(5):906-13. PubMed ID: 16163738
[TBL] [Abstract][Full Text] [Related]
48. Multiple functions of D-type cyclins can antagonize pRb-mediated suppression of proliferation.
Baker GL; Landis MW; Hinds PW
Cell Cycle; 2005 Feb; 4(2):330-8. PubMed ID: 15684604
[TBL] [Abstract][Full Text] [Related]
49. Epidermal growth factor-induced rapid retinoblastoma phosphorylation at Ser780 and Ser795 is mediated by ERK1/2 in small intestine epithelial cells.
Guo J; Sheng G; Warner BW
J Biol Chem; 2005 Oct; 280(43):35992-8. PubMed ID: 16126730
[TBL] [Abstract][Full Text] [Related]
50. Bisphenol S promotes the cell cycle progression and cell proliferation through ERα-cyclin D-CDK4/6-pRb pathway in MCF-7 breast cancer cells.
Lin Z; Zhang X; Zhao F; Ru S
Toxicol Appl Pharmacol; 2019 Mar; 366():75-82. PubMed ID: 30684532
[TBL] [Abstract][Full Text] [Related]
51. The ClC-3 chloride channel protein is a downstream target of cyclin D1 in nasopharyngeal carcinoma cells.
Zhang H; Zhu L; Zuo W; Luo H; Mao J; Ye D; Li Y; Liu S; Wei Y; Ye W; Chen L; Wang L
Int J Biochem Cell Biol; 2013 Mar; 45(3):672-83. PubMed ID: 23270726
[TBL] [Abstract][Full Text] [Related]
52. Attenuation of the retinoblastoma pathway in pancreatic neuroendocrine tumors due to increased cdk4/cdk6.
Tang LH; Contractor T; Clausen R; Klimstra DS; Du YC; Allen PJ; Brennan MF; Levine AJ; Harris CR
Clin Cancer Res; 2012 Sep; 18(17):4612-20. PubMed ID: 22761470
[TBL] [Abstract][Full Text] [Related]
53. Frequent deregulation of p16 and the p16/G1 cell cycle-regulatory pathway in neuroblastoma.
Diccianni MB; Omura-Minamisawa M; Batova A; Le T; Bridgeman L; Yu AL
Int J Cancer; 1999 Jan; 80(1):145-54. PubMed ID: 9935245
[TBL] [Abstract][Full Text] [Related]
54. Cyclin D1 promotes cell cycle progression through enhancing NDR1/2 kinase activity independent of cyclin-dependent kinase 4.
Du Z; Tong X; Ye X
J Biol Chem; 2013 Sep; 288(37):26678-87. PubMed ID: 23897809
[TBL] [Abstract][Full Text] [Related]
55. Overview of cyclins D1 function in cancer and the CDK inhibitor landscape: past and present.
Casimiro MC; Velasco-Velázquez M; Aguirre-Alvarado C; Pestell RG
Expert Opin Investig Drugs; 2014 Mar; 23(3):295-304. PubMed ID: 24387133
[TBL] [Abstract][Full Text] [Related]
56. Co-expression of cyclin D1 and phosphorylated ribosomal S6 proteins in hemimegalencephaly.
Aronica E; Boer K; Baybis M; Yu J; Crino P
Acta Neuropathol; 2007 Sep; 114(3):287-93. PubMed ID: 17483958
[TBL] [Abstract][Full Text] [Related]
57. A Cdk4/6-dependent phosphorylation gradient regulates the early to late G1 phase transition.
Kaulich M; Link VM; Lapek JD; Lee YJ; Glass CK; Gonzalez DJ; Dowdy SF
Sci Rep; 2021 Jul; 11(1):14736. PubMed ID: 34282211
[TBL] [Abstract][Full Text] [Related]
58. RN181 is a tumour suppressor in gastric cancer by regulation of the ERK/MAPK-cyclin D1/CDK4 pathway.
Wang S; Wang X; Gao Y; Peng Y; Dong N; Xie Q; Zhang X; Wu Y; Li M; Li JL
J Pathol; 2019 Jun; 248(2):204-216. PubMed ID: 30714150
[TBL] [Abstract][Full Text] [Related]
59. Human colorectal cancers with an intact p16/cyclin D1/pRb pathway have up-regulated p16 expression and decreased proliferation in small invasive tumor clusters.
Palmqvist R; Rutegârd JN; Bozoky B; Landberg G; Stenling R
Am J Pathol; 2000 Dec; 157(6):1947-53. PubMed ID: 11106567
[TBL] [Abstract][Full Text] [Related]
60. Regulation of mTOR function in response to hypoxia by REDD1 and the TSC1/TSC2 tumor suppressor complex.
Brugarolas J; Lei K; Hurley RL; Manning BD; Reiling JH; Hafen E; Witters LA; Ellisen LW; Kaelin WG
Genes Dev; 2004 Dec; 18(23):2893-904. PubMed ID: 15545625
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
